Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
17
NMPA:17
Drug Approvals
Drospirenone and Ethinylestradiol tablets
- Product Name
- 屈螺酮炔雌醇片
- Approval Number
- 国药准字H20249620
- Approval Date
- Dec 1, 2024
NMPA
Drospirenone and Ethinylestradiol Tablets （II）
- Product Name
- 屈螺酮炔雌醇片(Ⅱ)
- Approval Number
- 国药准字H20249192
- Approval Date
- Oct 29, 2024
NMPA
Desogestrel and Ethinyl Estradiol Tablets
- Product Name
- 去氧孕烯炔雌醇片
- Approval Number
- 国药准字H20244138
- Approval Date
- Jun 25, 2024
NMPA
Memantine Hydrochloride Sustained-release Capsules
- Product Name
- 盐酸美金刚缓释胶囊
- Approval Number
- 国药准字H20234076
- Approval Date
- Aug 29, 2023
NMPA
Memantine Hydrochloride Sustained-release Capsules
- Product Name
- 盐酸美金刚缓释胶囊
- Approval Number
- 国药准字H20234077
- Approval Date
- Aug 29, 2023
NMPA
Memantine Hydrochloride Sustained-release Capsules
- Product Name
- 盐酸美金刚缓释胶囊
- Approval Number
- 国药准字H20234078
- Approval Date
- Aug 29, 2023
NMPA
Memantine Hydrochloride Sustained-release Capsules
- Product Name
- 盐酸美金刚缓释胶囊
- Approval Number
- 国药准字H20234079
- Approval Date
- Aug 29, 2023
NMPA
Quetiapine Fumarate Extended-Release Tablets
- Product Name
- 富马酸喹硫平缓释片
- Approval Number
- 国药准字H20233394
- Approval Date
- Apr 4, 2023
NMPA
Quetiapine Fumarate Extended-Release Tablets
- Product Name
- 富马酸喹硫平缓释片
- Approval Number
- 国药准字H20233395
- Approval Date
- Apr 4, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found